lurasidone has been researched along with nan 190 in 1 studies
| Studies (lurasidone) | Trials (lurasidone) | Recent Studies (post-2010) (lurasidone) | Studies (nan 190) | Trials (nan 190) | Recent Studies (post-2010) (nan 190) |
|---|---|---|---|---|---|
| 6 | 0 | 3 | 245 | 0 | 33 |
| Protein | Taxonomy | lurasidone (IC50) | nan 190 (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 1A | Homo sapiens (human) | 0.003 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altamura, C; Arzuaga, A; Ciranna, L; Costa, L; Desaphy, JF; Lacivita, E; Leopoldo, M; Niso, M; Ragozzino, ME; Stama, ML | 1 |
1 other study(ies) available for lurasidone and nan 190
| Article | Year |
|---|---|
Privileged scaffold-based design to identify a novel drug-like 5-HT
Topics: Dose-Response Relationship, Drug; Drug Design; Fragile X Syndrome; HEK293 Cells; Humans; Molecular Structure; Piperazines; Receptors, Serotonin; Serotonin Receptor Agonists; Structure-Activity Relationship | 2020 |